Evidence map›Paper›PMID 29520384›Full record

ArticleInvestigative and clinical urology2018

What do patients with urothelial cancer know about the association of their tumor disease with smoking habits? Results of a German survey study.

Matthias May, Hans-Martin Fritsche, Christian Gilfrich, Mirja Dombrowski, Odilo Maurer, Philipp Spachmann, Manju Ganesh Kumar, Marc Bjurlin, Maximilian Burger, Sabine Brookman-May

Open access · diamondAbstract read
In one paragraph

Article in Investigative and clinical urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Matthias MayDepartment of Urology, St. Elisabeth Hospital Straubing, Straubing, Germany.ORCID 0000-0003-3896-0405
Hans-Martin FritscheDepartment of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Christian GilfrichDepartment of Urology, St. Elisabeth Hospital Straubing, Straubing, Germany.
Mirja DombrowskiDepartment of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Odilo MaurerDepartment of Urology, St. Elisabeth Hospital Straubing, Straubing, Germany.
Philipp SpachmannDepartment of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Manju Ganesh KumarDepartment of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Marc BjurlinDepartment of Urology, New York University Langone Hospital, New York University School of Medicine, New York, NY, USA.
Maximilian BurgerDepartment of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Sabine Brookman-MayDepartment of Urology, Ludwig-Maximilians University (LMU), Munich, Germany.
University of Regensburg · DEBarmherzige Brüder Klinikum St. Elisabeth in Straubing · DEJanssen (Belgium) · BENYU Langone Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Smoking represents a primary risk factor for the development of urothelial carcinoma (UC) and a relevant factor impacting UC-specific prognosis. Data on the accordant knowledge of UC-patients in this regard and the significance of physicians in the education of UC-patients is limited. Materials and Methods: Eighty-eight UC-patients were enrolled in a 23-items-survey-study aimed to analyse patient knowledge and awareness of their tumor disease with smoking along with physician smoking cessation counselling. Results: The median age of the study patients was 69 years; 26.1% (n=23), 46.6% (n=41), and 27.3% (n=24), respectively, were non-smokers, previous, and active smokers. Exactly 50% of active smokers reported a previous communication with a physician about the association of smoking and their tumor disease; however, only 25.0% were aware of smoking as main risk factor for UC development. Merely 33% of the active smokers had been prompted directly by their physicians to quit smoking. About 42% of active smokers had received the information that maintaining smoking could result in a tumor-specific impairment of their prognosis. Closely 29% of active and about 5% of previous smokers (during the time-period of active smoking) had been offered support from physicians for smoking cessation. No association was found between smoking anamnesis (p=0.574) and pack-years (p=0.912), respectively, and tumor stage of UC. Conclusions: The results of this study suggest that the medical conversation of physicians with UC-patients about the adverse significance of smoking is limited. Implementation of structured educational programs for smoking cessation may be an opportunity to further enhance comprehensive cancer care.

Indexed as

Carcinoma, Transitional CellPreventive Health ServicesSmokingUrinary Bladder NeoplasmsAgedFemaleGermanyHumansMaleMiddle AgedNeeds AssessmentPhysician-Patient RelationsPrognosisRisk FactorsSmoking CessationCigarette smokingHealth facility planningNeoplasm stagingSurveys and questionnairesUrinary bladder neoplasms

Identifiers

PMID29520384
PMCPMC5840123
OpenAlexW2789868804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.